Vårdpersonal

Activa RC Neurostimulator

Deep Brain Stimulation

Overview

The Activa RC neurostimulator is the first rechargeable deep brain stimulation device and is Medtronic's thinnest available on the market today with 9-year longevity. This dual-channel device is capable of delivering bilateral stimulation. Activa RC is typically implanted subcutaneously near the clavicle, and connected to an extension and leads, which are implanted in the brain.

The Activa Portfolio provides the unprecedented ability to control the stimulation field with innovative interleaved pulses and patient-specific therapy groups.


INDICATIONS

MEDTRONIC DBS THERAPY FOR PARKINSON'S DISEASE

Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic DBS Therapy for Parkinson's Disease is indicated for adjunctive therapy in reducing some of the symptoms in individuals with levodopa-responsive Parkinson's disease of at least 4 years' duration that are not adequately controlled with medication, including motor complications of recent onset (from 4 months to 3 years) or motor complications of longer-standing duration.

MEDTRONIC DBS THERAPY FOR TREMOR

Unilateral thalamic stimulation of the ventral intermediate nucleus of the thalamus (VIM) using Medtronic DBS Therapy for Tremor is indicated for the suppression of tremor in the upper extremity. The system is intended for use in patients who are diagnosed with Essential Tremor or Parkinsonian tremor not adequately controlled by medications and where the tremor constitutes a significant functional disability. The safety or effectiveness of this therapy has not been established for bilateral stimulation.


PRODUCT DETAILS

MR CONDITIONAL

Medtronic gives you the first safe* access to MRI anywhere on the body for diagnosing health conditions in DBS patients. Eligible patients with an Activa RC neurostimulator may have an MRI scan anywhere on the body under certain conditions. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems and DBS MRI Eligibility Sheet for a complete list of conditions and instructions for use (available on the Medtronic Manuals Library).

BATTERY PREDICTABILITY

Medtronic Activa neurostimulators ensure predictable battery life, and typically give warning when the neurostimulator battery reaches 8 years of operation. A replacement neurostimulator is needed within 12 months.

ADVANCED PROGRAMMING

  • Establish programming groups that may allow patients to reach optimized settings sooner
  • Achieve finer control over the stimulation field by delivering multiple programs per lead

DEVICE STORAGE

Patient-specific data — including historical settings and therapeutic response — is stored in the neurostimulator for easy access from the N'Vision programmer.

COMPATIBLE PRODUCTS

  • Lead model 3387
  • Lead model 3389
  • Extension model 37086
  • DBS tunneling tool kit model 3755
  • N'Vision clinician programmer model 8840
  • DBS patient programmer model 37642
  • Recharger model 37651

MANUALS AND TECHNICAL GUIDES

Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Activa RC) or model number (37612). 


MODEL SPECIFICATIONS

Model37612
Battery TypeRechargeable
Weight40 g (1.4 oz)
Height54 mm (2.1 in)
Length54 mm (2.1 in)
Channels2

*

Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions.